| DNA damage foci: Meaning and significance K Rothkamm, S Barnard, J Moquet, M Ellender, Z Rana, ... Environmental and molecular mutagenesis 56 (6), 491-504, 2015 | 345 | 2015 |
| ATR-dependent radiation-induced γH2AX foci in bystander primary human astrocytes and glioma cells S Burdak-Rothkamm, SC Short, M Folkard, K Rothkamm, KM Prise Oncogene 26 (7), 993-1002, 2007 | 230 | 2007 |
| Cytoplasmic irradiation induces mitochondrial-dependent 53BP1 protein relocalization in irradiated and bystander cells L Tartier, S Gilchrist, S Burdak-Rothkamm, M Folkard, KM Prise Cancer research 67 (12), 5872-5879, 2007 | 202 | 2007 |
| ATM acts downstream of ATR in the DNA damage response signaling of bystander cells S Burdak-Rothkamm, K Rothkamm, KM Prise Cancer research 68 (17), 7059-7065, 2008 | 138 | 2008 |
| Irradiation induces a biphasic expression of pro-inflammatory cytokines in the lung CE Rübe, F Wilfert, J Palm, J König, S Burdak-Rothkamm, L Liu, A Schuck, ... Strahlentherapie und Onkologie 180 (7), 442, 2004 | 130 | 2004 |
| Cohesin promotes the repair of ionizing radiation-induced DNA double-strand breaks in replicated chromatin C Bauerschmidt, C Arrichiello, S Burdak-Rothkamm, M Woodcock, MA Hill, ... Nucleic acids research 38 (2), 477-487, 2010 | 115 | 2010 |
| Prevalence of βIII-tubulin (TUBB3) expression in human normal tissues and cancers F Person, W Wilczak, C Hube-Magg, C Burdelski, C Möller-Koop, ... Tumor Biology 39 (10), 1010428317712166, 2017 | 79 | 2017 |
| New molecular targets in radiotherapy: DNA damage signalling and repair in targeted and non-targeted cells S Burdak-Rothkamm, KM Prise European journal of pharmacology 625 (1-3), 151-155, 2009 | 77 | 2009 |
| Establishment of the first well-differentiated human pancreatic neuroendocrine tumor model D Benten, Y Behrang, L Unrau, V Weissmann, G Wolters-Eisfeld, ... Molecular Cancer Research 16 (3), 496-507, 2018 | 67 | 2018 |
| Radiosensitivity of tumor cell lines after pretreatment with the EGFR tyrosine kinase inhibitor ZD1839 (Iressa®) S Burdak-Rothkamm, CE Rübe, TP Nguyen, D Ludwig, K Feldmann, ... Strahlentherapie und Onkologie 181 (3), 197, 2005 | 65 | 2005 |
| Radiation-induced bystander and systemic effects serve as a unifying model system for genotoxic stress responses S Burdak-Rothkamm, K Rothkamm Mutation Research/Reviews in Mutation Research 778, 13-22, 2018 | 55 | 2018 |
| BRCA1, FANCD2 and Chk1 are potential molecular targets for the modulation of a radiation-induced DNA damage response in bystander cells S Burdak-Rothkamm, K Rothkamm, K McClelland, ST Al Rashid, KM Prise Cancer letters 356 (2), 454-461, 2015 | 47 | 2015 |
| DNA and chromosomal damage in response to intermittent extremely low-frequency magnetic fields S Burdak-Rothkamm, K Rothkamm, M Folkard, G Patel, P Hone, D Lloyd, ... Mutation Research/Genetic Toxicology and Environmental Mutagenesis 672 (2 …, 2009 | 40 | 2009 |
| DNA Damage Repair Deficiency in Prostate Cancer S Burdak-Rothkamm, WY Mansour, K Rothkamm Trends in Cancer 6 (11), 974-984, 2020 | 31 | 2020 |
| High‐level glyoxalase 1 (GLO1) expression is linked to poor prognosis in prostate cancer C Burdelski, R Shihada, A Hinsch, A Angerer, C Göbel, E Friedrich, ... The Prostate 77 (15), 1528-1538, 2017 | 27 | 2017 |
| FGFR1 amplification is often homogeneous and strongly linked to the squamous cell carcinoma subtype in esophageal carcinoma K von Loga, J Kohlhaussen, L Burkhardt, R Simon, S Steurer, ... PloS one 10 (11), e0141867, 2015 | 22 | 2015 |
| Interplay between DNA replication stress, chromatin dynamics and DNA-damage response for the maintenance of genome stability M Mognato, S Burdak-Rothkamm, K Rothkamm Mutation Research/Reviews in Mutation Research, 108346, 2021 | 21 | 2021 |
| A functional ex vivo assay to detect PARP1‐EJ repair and radiosensitization by PARP‐inhibitor in prostate cancer S Köcher, B Beyer, T Lange, L Nordquist, J Volquardsen, ... International journal of cancer 144 (7), 1685-1696, 2019 | 21 | 2019 |
| DNA Damage Repair Deficiency and Synthetic Lethality for Cancer Treatment. S Burdak-Rothkamm, K Rothkamm Trends in Molecular Medicine 27 (1), 91-92, 2021 | 16 | 2021 |
| Radioprotection of targeted and bystander cells by methylproamine S Burdak-Rothkamm, A Smith, P Lobachevsky, R Martin, K Prise Strahlentherapie und Onkologie 191 (3), 248–255, 2014 | 15 | 2014 |
Kai RothkammHead, Radiobiology, University Medical Center Hamburg-EppendorfVerified email at uke.de
